Your browser doesn't support javascript.
loading
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.
García Rodríguez, Luis Alberto; Ruigómez, Ana; Schink, Tania; Voss, Annemarie; Smits, Elisabeth; Swart, Karin M A; Balabanova, Yanina; Suzart-Woischnik, Kiliana; Brobert, Gunnar; Herings, Ron M C.
Afiliación
  • García Rodríguez LA; Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain.
  • Ruigómez A; Centre for Pharmacoepidemiological Research (CEIFE), Madrid, Spain.
  • Schink T; Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Voss A; Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Smits E; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • Swart KMA; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • Balabanova Y; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
  • Suzart-Woischnik K; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
  • Brobert G; Bayer AB, Stockholm, Sweden.
  • Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Expert Opin Drug Saf ; 22(6): 493-500, 2023.
Article en En | MEDLINE | ID: mdl-36795067

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Accidente Cerebrovascular Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Opin Drug Saf Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Accidente Cerebrovascular Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Opin Drug Saf Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: España